Saved Results

No results saved yet.

Enter a patient name and hit Save on a result.

HomeEscore de Tokuhashi (Metástases Vertebrais)
Pin your most used calculators here by clicking the star in the dropdown.

Escore de Tokuhashi (Metástases Vertebrais)

Clinical Context & Background

O Escore de Tokuhashi Revisado (2005) é um sistema de pontuação prognóstica para pacientes com metástases vertebrais. Avalia o estado geral, metástases ósseas extraespinais, número de metástases vertebrais, metástases em órgãos internos, sítio primário e paralisia medular. A pontuação total auxilia na decisão entre cirurgia excisional, cirurgia paliativa ou manejo não cirúrgico.
Referência: Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976). 2005;30(15):1786-1792.
Formula Logic
Soma de 6 parâmetros (0-15 pontos).

Reference Data

Pontuação TotalSobrevida EstimadaEstratégia de Tratamento
0 - 8< 6 mesesConservador / Cirurgia Paliativa
9 - 11≥ 6 mesesCirurgia Paliativa / Radioterapia
12 - 15≥ 1 anoCirurgia Excisional provavelmente apropriada

Calculation verification history

Verified
  1. : Production browser revalidation

    • Three source-backed Tokuhashi cases passed through visible production controls at scores 0, 10, and 15 across all survival bands.
    • No unexpected N/A, literal undefined value, stale control, or browser-console error was observed.
    Download latest production check (Excel)

    Case-level evidence is retained in validation/browser-revalidation/tokuhashi-spine-metastases-prognosis-2026-08-03.json.

  2. : Production browser validation

    • Ten source-backed cases were exercised on the public production route through visible browser controls; 10/10 case records passed their expected-versus-observed assertions across 11 visible submissions.
    • Overall browser status: failed-console. medium: Production emitted minified React error #418 during route loads/reloads used by this run.
    • Case-level inputs, expected and observed results, reset/repeat behavior, failure reproductions, and console evidence are retained in the production-browser evidence record.

    Case-level production evidence is retained in validation/browser-production/tokuhashi-spine-metastases-prognosis.json.

  3. : Browser input adapter corrected and reverified

    • Accepted finite number values already normalized by the shared calculator form while retaining strict malformed-input rejection.
    • No equation, cutoff, unit, classification, or applicability rule changed; calculator-specific verification and the calculator-wide browser-input audit passed.
  4. : Full validation test

    • 1,666/1,666 exhaustive source-combination, count and score-boundary, strict-input, UI/reset, trace, wording, immutability, registry, and no-panel checks passed with zero score or classification mismatches.
    • Scope is the revised 2005 pretreatment score for established metastatic spinal tumors; no panel calculates Tokuhashi or inherits this verification.
  5. : Calculation and input-contract correction

    • Corrected the revised primary-site table: other primaries now score 2 points and kidney/uterus score 3 points, while rectum remains 4 and thyroid/prostate/breast/carcinoid remain 5.
    • Replaced favorable point-coded defaults and unsafe summation with six required source-semantic inputs, raw integer metastasis counts, exact-key validation, and rejection of missing, extra, coercive, fractional, nonfinite, or unsupported values.
    • Added an immutable six-contribution trace, exact 0-8, 9-11, and 12-15 historical survival rows, the correct publication citation, and explicit wording that vertebral multiplicity also informed the original treatment principles.

Verification confirms the calculator implementation against the cited model; it is not independent clinical validation, regulatory approval, or medical advice.

Found a possible issue? Report it to improve this calculator

Share This Calculator

Share:

Evidence-based oncology decision support. Verify with clinical guidelines.